Top

Published in:

01-12-2013 | Incidence study

Incretin mimetics: pancreatitis identified in daily clinical practice

Published in: Reactions Weekly | Issue 1/2013

Excerpt

There is an association between incretin-mimetic therapy and pancreatic damage, according to an article recently published in Expert Opinion on Drug Safety. Incretin mimetics, such as exenatide, bind to the glucagon-like peptide-1 receptor, stimulating glucose independent insulin release for patients with type 2 diabetes mellitus (T2DM). …

Incretin-mimetics associated pancreatitis: evidence from the spontaneous adverse drug reactions reporting in Italy. Expert Opinion on Drug Safety : [6 pages], 13 Nov 2013. Available from: URL: http://dx.doi.org/10.1517/14740338.2014.853036

Title: Incretin mimetics: pancreatitis identified in daily clinical practice
Publication date: 01-12-2013
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2013
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-013-7688-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Incretin mimetics: pancreatitis identified in daily clinical practice

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2013

Prednisolone

Clobetasol

Deferasirox

Fluorouracil/folinic acid/oxaliplatin

Octreotide

FDA eases restrictions on diabetic drug rosiglitazone